FDA Inspection 1078696 — Barbara Ann Karmanos Cancer Hospital
The FDA completed an inspection of Barbara Ann Karmanos Cancer Hospital on Feb 4, 2019 in Detroit, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 4, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Detroit, MI (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 17764 | 21 CFR 212.20(e) | Written QA procedures established, followed |
| 17849 | 21 CFR 212.60(a) | Testing procedures |